A drug-eluting resorbable scaffold was superior to angioplasty in treating infrapopliteal artery disease and chronic limb-threating ischemia and was noninferior for safety in the LIFE-BTK trial.
Direct endovascular thrombectomy for patients with acute ischemic stroke failed to achieve non-inferiority to combined bridging thrombolysis plus endovascular therapy, in a new meta-analysis.
A new position statement from the Society for Cardiovascular Angiography and Interventions suggests best practices for this increasingly widespread alternative access route.
Endovascular Stent Market has been evolving and changing over the course of past few decades and the market scope has changed a lot over the course of time and to better understand the market’s current landscape this report on Endovascular Stent market will be of great importance. The report has a detailed outlook o.
A new global registry shows differences in time to reperfusion and early response rate between various approaches used to remove clots, but neurological outcomes look similar with all strategies.